Deciphering Immunology's Dirty Secret

Deciphering Immunology's Dirty Secret Can innate immune adjuvants save vaccinology? By Kate Travis ARTICLE EXTRAS 1 Why, he wondered, did scientists have to include bits of bacteria or aluminum hydroxide with a vaccine to get an immune response? Janeway hypothesized and later proved that so-called pattern recognition receptors identify invading pathogens and trigger an immediate reaction against the i

Written byKate Travis
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Can innate immune adjuvants save vaccinology?
By Kate Travis

Indeed, what's old is new again. "We've known for a very long time that the body mounts an intense inflammatory response to microbes," says Bruce Beutler, professor of immunology at the Scripps Research Institute in La Jolla, Calif. Scientists even knew about what caused the response: In the 1890s Robert Koch and Richard Pfeiffer identified what they dubbed endotoxin, the complex molecule that coats Gram-negative bacteria. They found that endotoxin - later pegged specifically as lipopolysaccharide (LPS) - could induce fever and shock in guinea pigs.

Fly geneticists changed the name of the game. In 1996, scientists had learned that a fruit fly development gene called Toll also protected the flies from fungal infections. 2 In 1997, Janeway and Ruslan Medzhitov, then a postdoc at Yale, found that a known human gene, similar to the fly's Toll, could activate immune genes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies